Cofactor Genomics is a biotech company that focuses on drug development, medical research, and personalized medicine. It was founded in 2008 and has offices in St. Louis, San Diego, and San Francisco. The company has been involved in various research projects, including the preservation of endangered species and has received a $1.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH).

COFA

COM:COFACTORGENOMICS

Cofactor Genomics